Valens GroWorks Announces Additions to Management & Key Partnerships

On , In Press Releases

Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), a multi-licensed, vertically integrated provider of cannabis products and services with a focus on proprietary extraction processes is pleased to announce key additions to the Valens team in anticipation of Canada’s legalization of recreational cannabis use.

“These additions are crucial as we advance high-paced expansion plans across the company’s business verticals. I am extremely confident in the personnel chosen as they have a proven track record of leading exceptional positive growth at a rapid rate in related industries. The marketing teams joining us carry an impressionability with a global impact. I am excited to be able to say that with both Valens-branded products and vertically integrated production at the forefront of our expansion, our team will continue to grow very quickly over the coming months” commented Tyler Robson, Valens’ CEO.

Chris Buysen, MPAcc, CPA, CA – Chief Financial Officer

Mr. Buysen has over 15 years of diverse financial experience working as a senior financial executive with many public and private organizations in a wide range of industries including retail, pharmacy and consumer packaged goods. During this time, he was responsible for internal and external financial reporting, strategic planning, treasury, tax, information technology, human resources, financial controls and corporate governance.

Mr. Buysen’s experience enables him to manage the Company’s expected growth in the near term as the Company explores opportunities into international financial and retail markets.

Chantel Popoff – Vice President of Valens Agritech Ltd.

In 2007, Ms. Popoff was appointed Director of Operations, then Director of Marketing for a fast-growing Western Canadian retail pharmacy chain. She was responsible for overseeing operations, financial performance, and marketing for 21 locations. The pharmacy chain’s success led to an acquisition in 2012 by Shoppers Drug Mart. In January 2013, Ms. Popoff took the opportunity to join a Canadian natural health food company for a more fast-paced, entrepreneurial environment, leading the operations and marketing of a national product launch.  By late 2015, Ms. Popoff and her team had gained shelf placement in over 8,000 stores, while implementing standard operating procedures, financial reporting structure and national consumer and trade marketing programs to grow the brand and prepare the company for further growth. She was promoted to President of the company in 2016.

Her experience enabled her to successfully gain an in-depth understanding of both the retail pharmacy and retail health food space as well as the regulatory environment necessary to run pharmaceutical operations across Western Canada. With this cross-functional knowledge and over 15 years of hands-on senior management experience, Ms. Popoff joins Valens Agritech as Vice President, supporting the overall operations of the company.

Jesper Wahlberg & Sugar Media – Business and Marketing Strategy

Mr. Wahlberg founded Sugar Media, a Toronto-based marketing agency developing and executing best-in-class marketing initiatives for Tier One clients such as Chrysler, PayPal, Kubota and Fisher-Price. Sub-agency brand, CausePlay, guides some of Canada’s leading Not-for-Profit organizations by either re-igniting existing peer-to-peer fundraising or in the development of entirely new and highly democratized platforms. CausePlay clients include but are not limited to Sick Kids Hospital, The Canadian Olympic Foundation, United Way, Diabetes Canada, and Plan Canada.

Mr. Wahlberg and his team at Sugar Media will be providing Valens with strategic guidance and insights, working with the Valens marketing team as they continue to develop the Valens brand and go-to market strategy whether B2B or consumer focused.

Everett Knight – Vice President of Investor Relations and Business Development

Valens is excited to formally announce Everett Knight as Head of Investors Relations with a focus on corporate finance initiatives and business development.

Mr. Young has spent the past 15 years working in the capital market sectors of Canada, the United States and Europe. Beyond this, he has extensive business development experience in Hong Kong, North and South America. He has helped finance numerous start-up companies through his networks in energy, mining, technology and biotechnology. His expertise in finance, marketing and communications helps profile Valens to both retail and institutional investors globally.

Mass Minority – Marketing and Branding Strategy

Mass Minority is a consultancy led by Brett Channer, former CEO of Saatchi + Saatchi’s Canadian division, and Brent Rivard, former Global Managing Director of Anomaly, along with other tenured senior executives in the fields of Data Science, Business Design, Communications and Media Architecture. Mass Minority leverages proprietary data tools and methodologies along with today’s technology to evaluate, validate and structure opportunities for businesses to grow. They design accountable operating systems populated with adaptive content to drive unprecedented business results in a world that has shifted from Mass Consumption to Mass Personalization.

Mass Minority is working hand-in-hand with Valens’ development team in the fields of strategic brand direction, marketing, communications and product design.

About Valens GroWorks

Valens GroWorks Corp. is a vertically integrated provider of Canadian cannabis products developed from our proprietary extraction techniques, with three wholly-owned subsidiaries located in and around Kelowna, BC. Subsidiary Valens Agritech has initiated cannabis production, processing and sales under a Health Canada Dealer’s Licence, which includes a supply agreement with Canopy Growth Corporation under their extensive CraftGrow distribution network. Subsidiary Supra THC Services is a Health Canada licensed, ISO 17025 accredited cannabis testing lab providing sector-leading analytical services and has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant-Based Medicine Analytics. Subsidiary Valens Farms is in the process of becoming a purpose-built facility in compliance with European Union (EU) Good Manufacturing Practices (GMP) standards, ensuring the product from this facility can be exported anywhere in the world where Cannabis is nationally legal for medical or adult usage purposes.

For more information, please visit the Valens GroWorks, Valens Agritech and Valens Labs websites.

For further information, please contact:
Everett Knight

Notice Regarding Forward-Looking Statements

This news release contains certain “forward-looking statements” within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as “anticipates”, “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed”, “positioned” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Corporation is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

The CSE or other regulatory authority has not reviewed, approved or disapproved the contents of this press release. We seek Safe Harbour.